Increased risk of venous thromboembolism in splenectomized patients with sickle cell disease

Affiliations

• ¹ French National Reference Center for sickle cell disease, thalassaemia and other red blood cell and erythropoiesis disorders, Department of Internal Medicine, European Georges Pompidou Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris-Cité University Paris, Paris, France.
• ² Department of Internal Medicine, Henri-Mondor Hospital, AP-HP, Paris Est University, Créteil, France.
• ³ Reference Center for sickle cell disease, thalassemia and other red blood cell and erythropoiesis disorders, Biotherapy department, Necker Hospital, AP-HP, Paris-Cité University, Paris, France.
• ⁴ Laboratory of Excellence GR-Ex, Paris-Cité University, Paris, France.
• ⁵ INSERM U1163, CNRS 8254, IMAGINE Institute, Paris-Cité University, Paris, France.